
About Nabla
Nabla is a Healthcare company based in Boston (United States) founded in 2020 by Frances Anastassacos and Surge Biswas. Synthetic biology platform for functional protein identification is provided. It operates on a AI-as-a-Service and Professional Services model. Nabla has raised $37 million across 3 funding rounds from investors including Khosla Ventures, Radical Ventures and Zetta Venture Partners. Its chief executive, as recorded, is Surge Biswas. Nabla offers products and services including Antibody Design Platform. Its focus areas include Biotechnology and Drug Discovery. Its legal entity is Nabla Bio, Inc.
Company details
Nabla is engaged in developing integrated AI and experimental technologies for drug design. The company is based in Cambridge, MA, and focuses on creating generative models and multiplexed screens for antibody design. Solutions are targeted at challenging disease targets like GPCRs and ion channels. Partnerships with leading pharmaceutical companies are established to maximize impact. The integration of AI-guided design with wet-lab experimentation is emphasized to enhance manufacturability, safety, and efficacy of drugs for complex diseases.
- Total Equity Funding$37M (USD)
in 3 rounds
- Latest Funding Round$26M (USD), Series A
May 2024
- InvestorsKhosla Ventures
& 5 more
Products & Services of Nabla
Nabla offers a comprehensive portfolio of products and services, including Antibody Design Platform.
Antibodies are designed with AI and experimental technologies.
Funding Insights of Nabla
Nabla has successfully raised a total of $37M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $26 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $37M
- Total Rounds 3
- Last Round Series A β $26M
- First Round $256,000
(Apr 2021)
- Investors Count 6
All 3 funding rounds of Nabla with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $26M | Series A | β | Radical Ventures | β |
| Dec 2021 | $11M | Seed | β | Khosla Ventures, Zetta Venture Partners | |
| Apr 2021 | $256,000 | Grant | β | β |
6 investors in total: 6 institutional.
Investors in Nabla
Nabla has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Khosla Ventures, Radical Ventures and Zetta Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on AI-driven companies | radical.vc | Toronto, Canada | ||
Early-stage startups are funded by this venture capital firm. | 2004 | khoslaventures.com | Menlo Park, United States | |
Seed and early-stage tech investments are made in the US. | zettavp.com | San Francisco, United States | ||
Venture capital firm focused on multiple sectors | fiftyyears.com | San Francisco, United States | ||
Seed stage tech-focused VC firm investing primarily in the US | cantos.vc | San Francisco, United States | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Nabla
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nabla
8 people are tracked at Nabla (2 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Frances Anastassacos | Co-Founder | Leadership |
Surge Biswas | Co-Founder & CEO | Leadership |
Mark Desimone | Scientist | Team |
Bridget Li | ML Scientist I | Team |
Sunita Subramanian | Senior Scientist | Team |
Vinicius Reis | Senior ML Scientist | Team |
Connor Blankenship | Senior Scientist | Team |
Adithya Paramasivam | ML Scientist | Team |
Complete people profiles for Nabla
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nabla
3 dated milestones of Nabla across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Nabla is founded.
- Funding First funding round of $256K.
- Funding Latest funding round, Series A, of $26.0M.
Web traffic of Nabla
The website of Nabla (nabla.bio) receives about 8.2K visits a month.
- Monthly visits8.2K
▼ 3% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Nabla (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
